We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
(+5%)
Cap. Flow
+$6.41B
Cap. Flow
% of AUM
5.41%
Top 10 Holdings %
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.02B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$944M |
| 3 |
AT&T
T
|
+$753M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$553M |
| 5 |
Linde
LIN
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$331M |
| 2 |
FDC
First Data Corporation
FDC
|
+$331M |
| 3 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$312M |
| 4 |
Blackstone
BX
|
+$277M |
| 5 |
FirstEnergy
FE
|
+$261M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.59% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.31% |
| 4 | Consumer Discretionary | 6.45% |
| 5 | Communication Services | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FARM
3776
DELISTED
Farmer Brothers
FARM
| $168K | ﹤0.01% |
12,977
-19
| -0.1% | -$274 |
|
3777
Cyclerion Therapeutics
CYCN
$14.9M
| $167K | ﹤0.01% |
691
+132
| +24% | +$28.5K |
|
3778
CALL
Teekay
TK
$1.01B
| $166K | ﹤0.01% |
41,500
| – | – |
|
3779
OneSpaWorld
OSW
$2.61B
| $163K | ﹤0.01% |
+10,476
| New | +$164K |
|
3780
Spok Holdings
SPOK
$228M
| $163K | ﹤0.01% |
13,608
+1,910
| +16% | +$24.7K |
|
3781
PUT
Green Plains
GPRE
$1.18B
| $162K | ﹤0.01% |
15,300
| – | – |
|
|
FRBK
3782
DELISTED
Republic First Bancorp Inc
FRBK
| $162K | ﹤0.01% |
38,607
+2,791
| +8% | +$12.1K |
|
|
SRNE
3783
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $161K | ﹤0.01% |
75,198
+3,668
| +5% | +$8.55K |
|
|
AGEN
3784
Agenus
AGEN
$312M
| $159K | ﹤0.01% |
3,165
-139
| -4% | -$7.44K |
|
3785
BlackRock MuniYield New York Quality Fund
MYN
$372M
| $159K | ﹤0.01% |
12,200
| – | – |
|
3786
Arcus Biosciences
RCUS
$3.55B
| $157K | ﹤0.01% |
17,264
+1,877
| +12% | +$15.1K |
|
3787
Metallus
MTUS
$838M
| $157K | ﹤0.01% |
24,863
-4,130
| -14% | -$27.1K |
|
|
AGS
3788
DELISTED
PlayAGS
AGS
| $155K | ﹤0.01% |
15,123
-24,926
| -62% | -$354K |
|
|
HUD
3789
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $155K | ﹤0.01% |
12,589
-332
| -3% | -$4.11K |
|
|
KNDI
3790
Kandi Technologies Group
KNDI
$67.5M
| $153K | ﹤0.01% |
32,780
+20,880
| +175% | +$108K |
|
3791
Kiniksa Pharmaceuticals
KNSA
$5.8B
| $153K | ﹤0.01% |
+18,011
| New | +$199K |
|
3792
Alpha and Omega Semiconductor
AOSL
$950M
| $151K | ﹤0.01% |
12,311
+1,390
| +13% | +$15.4K |
|
3793
Titan International
TWI
$466M
| $149K | ﹤0.01% |
55,309
-20,870
| -27% | -$68.7K |
|
|
CASA
3794
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $149K | ﹤0.01% |
18,988
-641
| -3% | -$4.3K |
|
|
ZYXI
3795
DELISTED
Zynex
ZYXI
| $147K | ﹤0.01% |
+17,073
| New | +$139K |
|
|
SMC
3796
Summit Midstream
SMC
$426M
| $147K | ﹤0.01% |
2,007
-2,123
| -51% | -$195K |
|
|
ONIT
3797
Onity Group
ONIT
$309M
| $144K | ﹤0.01% |
5,136
+100
| +2% | +$2.79K |
|
3798
SandRidge Energy
SD
$514M
| $142K | ﹤0.01% |
30,267
+1,251
| +4% | +$7.17K |
|
|
QTT
3799
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
| $142K | ﹤0.01% |
3,832
+1,625
| +74% | +$68.7K |
|
3800
KLX Energy Services
KLXE
$45M
| $141K | ﹤0.01% |
3,268
+278
| +9% | +$18.5K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q3 2019 Portfolio in Review
As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.
- Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
- Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
- Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
- Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
- Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
- Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
- Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.
Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.